Skip to main content

Neuroendocrine Neoplasms

  • Chapter
  • First Online:
Imaging and Pathology of Pancreatic Neoplasms

Abstract

Pancreatic neuroendocrine neoplasms (PanNENs) are tumors with neuroendocrine differentiation and are divided into functioning (syndromic) or non-functioning based on the clinical syndromes. Insulinomas are the most common functioning NETs. Non-functioning neuroendocrine tumors (NFNETs) account for up to 70–80% of all pancreatic NTEs. Pancreatic NFNETs are discovered incidentally or become clinically noticeable because of their large size.

The diagnosis of pancreatic NENs is usually based on clinical and biochemical workup. Imaging is needed to localize the functioning tumor and characterize the non-functioning tumor providing local and distant staging.

The current chapter is based on the original chapter written by Paola Capelli, Mirko D’Onofrio, Stefano Crosara, Paolo Tinazzi Martini, Riccardo De Robertis, Matteo Fassan, Stefano Gobbo, Aldo Scarpa, and Roberto Pozzi Mucelli in the previous edition of the book.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Procacci C, Biasiutti C, Carbognin G, et al. Pancreatic neoplasms and tumor-like conditions. Eur Radiol. 2001;11(Suppl 2):S167–92.

    Google Scholar 

  2. Dixon E, Pasieka JL. Functioning and nonfunctioning neuroendocrine tumors of the pancreas. Curr Opin Oncol. 2007;19:30–5.

    Article  PubMed  Google Scholar 

  3. Fischer L, Kleeff J, Esposito I, et al. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumors of the pancreas. Br J Surg. 2008;95:627–35.

    Article  CAS  PubMed  Google Scholar 

  4. Guilmette JM, Nosé V. Neoplasms of the neuroendocrine pancreas: an update in the classification, definition, and molecular genetic advances. Adv Anat Pathol. 2019;26(1):13–30.

    Article  CAS  PubMed  Google Scholar 

  5. Crona J, Skogseid B. Genetics of neuroendocrine tumors. Eur J Endocrinol. 2016;174(6):R275–90.

    Article  CAS  PubMed  Google Scholar 

  6. Iacovazzo D, Flanagan SE, Walker E, et al. MAFA missense mutation causes familial insulinomatosis and diabetes mellitus. Proc Natl Acad Sci U S A. 2018;115(5):1027–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Tortora G, Amato E, Pederzoli P, Scarpa A, Chang DK, Nones K, et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature. 2017;543:65–7.

    Article  PubMed  Google Scholar 

  8. Hruban RH, Pitman MB, Klimstra DS, American Registry of Pathology, Armed Forces Institute of Pathology (US). Tumors of the pancreas. Washington, DC: Armed Forces Institute of Pathology; 2007.

    Google Scholar 

  9. D’Onofrio M, Gallotti A, Pozzi Mucelli R. Imaging techniques in pancreatic tumors. Expert Rev Med Dev. 2010;7:257–73.

    Article  Google Scholar 

  10. O’Grady HL, Conlon KC. Pancreatic neuroendocrine tumors. Eur J Surg Oncol. 2008;34:324–32.

    Article  PubMed  Google Scholar 

  11. Tamm EP, Kim EE, Chaan S. Imaging of neuroendocrine tumors. Hematol Oncol Clin N Am. 2007;21:409–32.

    Article  Google Scholar 

  12. Lee LS. Diagnosis of pancreatic neuroendocrine tumors and the role of endoscopic ultrasound. Gastroenterol Hepatol. 2010;6:520–2.

    Google Scholar 

  13. Ros PR, Mortele KJ. Imaging features of pancreatic neoplasms. JBR-BTR. 2001;84:239–49.

    CAS  PubMed  Google Scholar 

  14. Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–42.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Yachida S, Vakiani E, White CM, et al. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol. 2012;36(2):173–84.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Bosman FT, World Health Organization, International Agency for Research on Cancer. WHO classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer; 2010.

    Google Scholar 

  17. Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. 5th ed. Lyon; 2019. ISBN 978-92-832-4499-8.

    Google Scholar 

  18. Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th ed. IARC press; 2016. ISBN: 978-1-119-26357-9.

    Google Scholar 

  19. Inzani F, Petrone G, Rindi G. The New World health organization classification for pancreatic neuroendocrine neoplasia. Endocrinol Metab Clin N Am. John Wiley & Sons, Ltd. Hoboken, NJ, USA; 2018;47(3):463–70.

    Google Scholar 

  20. Capelli P, Martignoni G, Pedica F, et al. Endocrine neoplasms of the pancreas: pathologic and genetic features. Arch Pathol Lab Med. 2009;133:350–64.

    Article  PubMed  Google Scholar 

  21. Malago R, D’Onofrio M, Zamboni GA, et al. Contrast-enhanced sonography of nonfunctioning pancreatic neuroendocrine tumors. Am J Roentgenol. 2009;192:424–30.

    Article  Google Scholar 

  22. D’Onofrio M, Mansueto GC, Falconi M, et al. Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography. Abdom Imaging. 2004;29:246–58.

    Article  PubMed  Google Scholar 

  23. Procacci C, Carbognin G, Accordini S, et al. Nonfunctioning endocrine tumors of the pancreas: possibilities of spiral CT characterization. Eur Radiol. 2001;11:1175–83.

    Article  CAS  PubMed  Google Scholar 

  24. Eriksson B, Orlefors H, Oberg K, et al. Developments in PET for the detection of endocrine tumours. Best Pract Res Clin Endocrinol Metab. 2005;19:311–24.

    Article  CAS  PubMed  Google Scholar 

  25. Koyama K, Okamura T, Kawabe J, et al. Diagnostic usefulness of FDG PET for pancreatic mass lesions. Ann Nucl Med. 2001;15:217–24.

    Article  CAS  PubMed  Google Scholar 

  26. Papos M, Takacs T, Pavics L, et al. The role of FDG-PET scan in the diagnosis of pancreatic carcinoma. Orv Hetil. 2002;43:1283–6.

    Google Scholar 

  27. Pasquali C, Rubello D, Sperti C, et al. Neuroendocrine tumor imaging, can 18F-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior? World J Surg. 1998;22:588–92.

    Article  CAS  PubMed  Google Scholar 

  28. Dietrich CF, Hocke M, Gallotti A, D’Onofrio M. Solid pancreatic tumors. In: D’Onofrio M, editor. Ultrasonography of the pancreas. Berlin, Heidelberg/New York: Springer; 2012. p. 93–110.

    Chapter  Google Scholar 

  29. Martinez-Noguera A, D’Onofrio M. Ultrasonography of the pancreas. 1. Conventional imaging. Abdom Imaging. 2007;32:136–49.

    Article  CAS  PubMed  Google Scholar 

  30. Hohl C, Schmidt T, Honnef D, et al. Ultrasonography of the pancreas. 2. Harmonic imaging. Abdom Imaging. 2007;32:150–60.

    Article  CAS  PubMed  Google Scholar 

  31. D’Onofrio M, Mansueto G, Vasori S, et al. Contrast-enhanced ultrasonographic detection of small pancreatic insulinoma. J Ultrasound Med. 2003;22:413–7.

    Article  PubMed  Google Scholar 

  32. D’Onofrio M, Zamboni G, Faccioli N, et al. Ultrasonography of the pancreas. 4. Contrast-enhanced imaging. Abdom Imaging. 2007;32:171–81.

    Article  PubMed  Google Scholar 

  33. Jung SE, Seung EJ, Kang HL, et al. CT and MR imaging findings of endocrine tumor of the pancreas according to WHO classification. Eur J Radiol. 2007;62:371–7.

    Article  PubMed  Google Scholar 

  34. Rockall AG, Reznek RH. Imaging of neuroendocrine tumors (CT/MR/US). Best Pract Res Clin Endocrinol Metab. 2007;21(1):43–68.

    Article  CAS  PubMed  Google Scholar 

  35. Horton KM, Hruban RH, Yeo C, et al. Multi-detector row CT of pancreatic islet cell tumors. Radiographics. 2006;26:453–64.

    Article  PubMed  Google Scholar 

  36. McAuley G, Delaney H, Colville J, et al. Multimodality preoperative imaging pancreatic insulinomas. Clin Radiol. 2005;60:1039–50.

    Article  CAS  PubMed  Google Scholar 

  37. D’Assignies G, Couvelard A, Bahrami S, et al. Pancreatic endocrine tumors, tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology. 2009;250(2):407–16.

    Article  PubMed  Google Scholar 

  38. Owen NJ, Sohaib SA, Peppercorn PD, et al. MRI of pancreatic neuroendocrine tumors. Br J Radiol. 2001;74:968–73.

    Article  CAS  PubMed  Google Scholar 

  39. Nishie A, Obuchi M, Howe J, et al. Small islet cell tumour in the pancreas, diagnostic value of diffusion-weighted MRI. J Med Imaging Radiat Oncol. 2008;52(4):374–5.

    Article  CAS  PubMed  Google Scholar 

  40. Furukawa H, Mukai K, Kosuge T, et al. Nonfunctioning islet cell tumors of the pancreas: clinical, imaging and pathological aspects in 16 patients. Jpn J Clin Oncol. 1998;28:255–61.

    Article  CAS  PubMed  Google Scholar 

  41. Hoff A, Cote G, Gagel R. Management of neuroendocrine cancers of the gastrointestinal tract: islet cell carcinoma of the pancreas and other neuroendocrine carcinomas. In: Abbruzzese J, Evans D, Willett C, Fenoglio-Preiser C, editors. Gastrointestinal oncology. New York: Oxford University Press; 2004. p. 780–800.

    Google Scholar 

  42. Demos TC, Posniak HV, Harmath C, et al. Cystic lesions of the pancreas. AJR Am J Roentgenol. 2002;179:1375–88.

    Article  PubMed  Google Scholar 

  43. Roggli VL, Judge DM, McGavran MH. Duodenal glucagonoma: a case report. Hum Pathol. 1979;10:350–3.

    Article  CAS  PubMed  Google Scholar 

  44. Capelli P, Parisi A. Pancreatic lesions: pathologic correlation. Chapter 12. In: D’Onofrio M, editor. Ultrasonography of the pancreas. Imaging and pathologic correlations. Berlin, Heidelberg/New York: Springer; 2012. p. 165–86.

    Chapter  Google Scholar 

  45. Graziani R, Brandalise A, Bellotti M, et al. Imaging of neuroendocrine gastroenteropancreatic tumours. Radiol Med. 2010;115:1047–64.

    Article  CAS  PubMed  Google Scholar 

  46. Bordeianou L, Vagefi PA, Sahani D, et al. Cystic pancreatic endocrine neoplasms: a distinct tumor type? J Am Coll Surg. 2008;206:1154–8.

    Article  PubMed  Google Scholar 

  47. Shimizu K, Shiratori K, Toki F, et al. Nonfunctioning islet cell tumor with a unique pattern of tumor growth. Dig Dis Sci. 1999;44:547–51.

    Article  CAS  PubMed  Google Scholar 

  48. Yazawa N, Imaizumi T, Okada K, et al. Nonfunctioning pancreatic endocrine tumor with extension into the main pancreatic duct: report of a case. Surg Today. 2011;41:737–40.

    Article  PubMed  Google Scholar 

  49. Heller SJ, Ferrari AP, Carr-Locke DL, et al. Pancreatic duct stricture caused by islet cell tumors. Am J Gastroenterol. 1996;91:147–9.

    CAS  PubMed  Google Scholar 

  50. Uemura K, Murakami Y, Hayashidani Y, et al. Main pancreatic duct obstruction due to a small nonfunctioning endocrine tumor of the pancreas. Hiroshima J Med Sci. 2009;58:45–8.

    PubMed  Google Scholar 

  51. Powell AC, Hajdu CH, Megibow AJ, et al. Nonfunctioning pancreatic endocrine neoplasm presenting as asymptomatic, isolated pancreatic duct stricture: a case report and review of the literature. Am Surg. 2008;74:168–71.

    Article  PubMed  Google Scholar 

  52. Ogawa M, Kawaguchi Y, Maruno A, et al. Small serotonin-positive pancreatic endocrine tumors caused obstruction of the main pancreatic duct. World J Gastroenterol. 2012;18:6669–73.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Koljenovic S, van Eijck CH, den Bakker MA. Pigmented black neuroendocrine tumour of the pancreas diagnosed by fine needle aspiration cytology. Cytopathology. 2010;21:270–2.

    Article  CAS  PubMed  Google Scholar 

  54. Smith AE, Levi AW, Nadasdy T, et al. The pigmented “black” neuroendocrine tumor of the pancreas: a question of origin. Cancer. 2001;92:1984–91.

    Article  CAS  PubMed  Google Scholar 

  55. Fryer E, Serra S, Chetty R. Lipid-rich (“clear cell”) neuroendocrine tumors of the pancreas in MEN I patients. Endocr Pathol. 2012;23:243–6.

    Article  CAS  PubMed  Google Scholar 

  56. Singh R, Basturk O, Klimstra DS, et al. Lipid-rich variant of pancreatic endocrine neoplasms. Am J Surg Pathol. 2006;30:194–200.

    Article  PubMed  Google Scholar 

  57. Ligneau B, Lombard-Bohas C, Partensky C, et al. Cystic endocrine tumors of the pancreas: clinical, radiologic, and histopathologic features in 13 cases. Am J Surg Pathol. 2001;25:752–60.

    Article  CAS  PubMed  Google Scholar 

  58. Sidden CR, Mortele KJ. Cystic tumors of the pancreas: ultrasound, computed tomography, and magnetic resonance imaging features. Semin Ultrasound CT MR. 2007;28:339–56.

    Article  PubMed  Google Scholar 

  59. Deshpande V, Lauwers GY. Cystic pancreatic endocrine tumor: a variant commonly confused with cystic adenocarcinoma. Cancer. 2007;111:47–53.

    Article  PubMed  Google Scholar 

  60. Tamagno G, Maffei P, Pasquali C, et al. Clinical and diagnostic aspects of cystic insulinoma. Scand J Gastroenterol. 2005;40:1497–501.

    Article  PubMed  Google Scholar 

  61. Zamboni G, Pea M, Martignoni G, et al. Clear cell “sugar” tumor of the pancreas. A novel member of the family of lesions characterized by the presence of perivascular epithelioid cells. Am J Surg Pathol. 1996;20:722–30.

    Article  CAS  PubMed  Google Scholar 

  62. Buetow PC, Miller DL, Parrino TV. Islet cell tumors of the pancreas: clinical, radiologic, and pathologic correlation in diagnosis and localization. Radiographics. 1999;17:453–72.

    Article  Google Scholar 

  63. D’Onofrio M, et al. Pancreas. In: Weskott HP, editor. Contrast-enhanced ultrasound. Bremen: UNI-MED Verlag AG; 2011.

    Google Scholar 

  64. Klein KA, Stephens SH, Welch TJ. Imaging of metastatic disease to the pancreas (abstr). Radiology. 1995;197:501.

    Google Scholar 

  65. Rindi G, Kloppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395–401.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Bertolotto M, D’Onofrio M, Martone E, et al. Ultrasonography of the pancreas. 3. Doppler imaging. Abdom Imaging. 2007;32(2):161–70.

    Article  CAS  PubMed  Google Scholar 

  67. Becker D, Strobel D, Bernatik T, et al. Echo-enhanced color and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc. 2001;53:784–9.

    Article  CAS  PubMed  Google Scholar 

  68. Singhi AD, Chu LC, Tatsas AD, et al. Cystic pancreatic neuroendocrine tumors: a clinicopathologic study. Am J Surg Pathol. 2012;36(11):1666–73.

    Article  PubMed  Google Scholar 

  69. Cloyd JM, Kopecky KE, Norton JA, et al. Neuroendocrine tumors of the pancreas: degree of cystic component predicts prognosis. Surgery. 2016;160(3):708–13.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Riccardo De Robertis .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

De Robertis, R. et al. (2022). Neuroendocrine Neoplasms. In: D'Onofrio, M., Capelli, P., Pederzoli, P. (eds) Imaging and Pathology of Pancreatic Neoplasms. Springer, Cham. https://doi.org/10.1007/978-3-031-09831-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-09831-4_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-09830-7

  • Online ISBN: 978-3-031-09831-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics